| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 153 | 2020 |
| A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients M Bartoletti, M Giannella, R Lewis, P Caraceni, S Tedeschi, M Paul, ... Clinical Microbiology and Infection 24 (5), 546. e1-546. e8, 2018 | 100 | 2018 |
| The periodic solution of van der Pol's equation A Buonomo SIAM Journal on Applied Mathematics 59 (1), 156-171, 1998 | 88 | 1998 |
| Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: prevalence, predictive factors, therapeutic outcome L Santarpia, A Buonomo, MC Pagano, L Alfonsi, M Foggia, M Mottola, ... Clinical Nutrition 35 (6), 1394-1398, 2016 | 82 | 2016 |
| Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? C Nardelli, I Gentile, M Setaro, C Di Domenico, B Pinchera, AR Buonomo, ... Frontiers in cellular and infection microbiology 11, 625581, 2021 | 72 | 2021 |
| Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver … I Gentile, R Scotto, C Coppola, L Staiano, DC Amoruso, T De Simone, ... Hepatology international 13, 66-74, 2019 | 71 | 2019 |
| The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C I Gentile, AE Maraolo, AR Buonomo, E Zappulo, G Borgia Expert opinion on drug discovery 10 (12), 1363-1377, 2015 | 71 | 2015 |
| Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection I Gentile, AR Buonomo, F Borgia, G Castaldo, G Borgia Expert opinion on investigational drugs 23 (4), 561-571, 2014 | 69 | 2014 |
| Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis AR Buonomo, E Zappulo, G Viceconte, R Scotto, G Borgia, I Gentile Expert Opinion on Drug Safety 17 (7), 709-717, 2018 | 66 | 2018 |
| Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A I Gentile, F Borgia, N Coppola, AR Buonomo, G Castaldo, G Borgia Current medicinal chemistry 21 (12), 1391-1404, 2014 | 65 | 2014 |
| Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C N Coppola, I Gentile, G Pasquale, AR Buonomo, N Capoluongo, ... Annals of hepatology 13 (1), 20-26, 2014 | 64 | 2014 |
| Modelling and analysis of differential VCOs A Buonomo, AL Schiavo International Journal of Circuit Theory and Applications 32 (3), 117-131, 2004 | 62 | 2004 |
| Asymptotic formulas in nearly sinusoidal nonlinear oscillators A Buonomo, C Di Bello IEEE Transactions on Circuits and Systems I: Fundamental Theory and …, 1996 | 61 | 1996 |
| Analysis of emitter (source)-coupled multivibrators A Buonomo, AL Schiavo IEEE Transactions on Circuits and Systems I: Regular Papers 53 (6), 1193-1202, 2006 | 57 | 2006 |
| MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection I Gentile, AR Buonomo, F Borgia, E Zappulo, G Castaldo, G Borgia Expert opinion on investigational drugs 23 (5), 719-728, 2014 | 56 | 2014 |
| Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world? I Gentile, AR Buonomo, E Zappulo, G Borgia Expert review of anti-infective therapy 12 (7), 763-773, 2014 | 55 | 2014 |
| Nirmatrelvir/ritonavir and molnupiravir in the treatment of mild/moderate COVID-19: results of a real-life study I Gentile, R Scotto, N Schiano Moriello, B Pinchera, R Villari, E Trucillo, ... Vaccines 10 (10), 1731, 2022 | 54 | 2022 |
| Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus I Gentile, E Zappulo, AR Buonomo, G Borgia Expert review of anti-infective therapy 12 (7), 775-782, 2014 | 50 | 2014 |
| Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection I Gentile, AR Buonomo, E Zappulo, G Minei, F Morisco, F Borrelli, ... Therapeutics and clinical risk management, 493-504, 2014 | 48 | 2014 |
| Analytical approach to the study of injection-locked frequency dividers A Buonomo, AL Schiavo IEEE Transactions on Circuits and Systems I: Regular Papers 60 (1), 51-62, 2012 | 48 | 2012 |
